KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Non-Current Deffered Revenue (2016 - 2022)

Jazz Pharmaceuticals has reported Non-Current Deffered Revenue over the past 13 years, most recently at $116000.0 for Q3 2022.

  • Quarterly Non-Current Deffered Revenue fell 88.24% to $116000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $116000.0 through Sep 2022, down 88.24% year-over-year, with the annual reading at $463000.0 for FY2021, 80.0% down from the prior year.
  • Non-Current Deffered Revenue was $116000.0 for Q3 2022 at Jazz Pharmaceuticals, down from $231000.0 in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $13.6 million in Q1 2018 and troughed at $116000.0 in Q3 2022.
  • The 5-year median for Non-Current Deffered Revenue is $3.6 million (2020), against an average of $4.8 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: plummeted 38.41% in 2019 and later crashed 88.24% in 2022.
  • Tracing JAZZ's Non-Current Deffered Revenue over 5 years: stood at $9.6 million in 2018, then plummeted by 49.26% to $4.9 million in 2019, then crashed by 52.38% to $2.3 million in 2020, then tumbled by 80.0% to $463000.0 in 2021, then tumbled by 74.95% to $116000.0 in 2022.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $116000.0, $231000.0, and $347000.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.